CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 8.69
-0.16 (-1.81%)
Aug 14, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | - | 6,090 | 6,777 | 12,015 | 10,298 | 9,284 |
Short-Term Investments | - | 4,283 | 2,360 | 1,750 | 4,268 | 2,024 |
Cash & Short-Term Investments | 10,373 | 10,373 | 9,137 | 13,765 | 14,566 | 11,307 |
Cash Growth | 13.52% | 13.52% | -33.62% | -5.50% | 28.82% | 21.38% |
Accounts Receivable | - | 8,694 | 9,542 | 9,712 | 6,736 | 6,508 |
Other Receivables | - | 92.55 | 79.18 | 129.65 | 100.05 | 39.78 |
Receivables | - | 8,787 | 9,621 | 9,841 | 6,836 | 6,549 |
Inventory | - | 3,091 | 3,130 | 3,139 | 2,555 | 2,480 |
Total Current Assets | - | 22,251 | 21,888 | 26,745 | 23,957 | 20,337 |
Property, Plant & Equipment | - | 13,489 | 12,503 | 11,643 | 10,977 | 9,564 |
Long-Term Investments | - | 7,109 | 6,271 | 4,596 | 3,720 | 3,323 |
Goodwill | - | 234.9 | 234.9 | 234.9 | 234.9 | 149.98 |
Other Intangible Assets | - | 2,658 | 2,518 | 2,146 | 1,872 | 425.87 |
Long-Term Deferred Tax Assets | - | 211.51 | 250.3 | 186.78 | 113.03 | 43 |
Long-Term Deferred Charges | - | 116.92 | 91.8 | 52.53 | 35.81 | 41.98 |
Other Long-Term Assets | - | 628.05 | 632.23 | 678.51 | 859.31 | 857.51 |
Total Assets | - | 46,698 | 44,389 | 46,282 | 41,770 | 34,742 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 3,409 | 2,988 | 2,889 | 2,206 | 1,770 |
Accrued Expenses | - | 3,613 | 3,821 | - | 3,922 | 3,166 |
Short-Term Debt | - | 307.72 | 364.2 | 441.27 | 145.64 | - |
Current Portion of Long-Term Debt | - | 21 | 28 | 8.95 | 7.84 | - |
Current Portion of Leases | - | 131.69 | 58.99 | 149.63 | 142.07 | 38.42 |
Current Income Taxes Payable | - | 229.13 | 137.51 | 379.45 | 261.61 | 260.73 |
Current Unearned Revenue | - | 896.2 | 538.05 | 494.9 | 940.5 | 645.75 |
Other Current Liabilities | - | 1,570 | 1,697 | 5,820 | 1,333 | 1,346 |
Total Current Liabilities | - | 10,178 | 9,634 | 10,183 | 8,958 | 7,226 |
Long-Term Debt | - | - | - | - | 28.95 | - |
Long-Term Leases | - | 180.69 | 56.14 | 107.06 | 258.04 | 55.62 |
Long-Term Unearned Revenue | - | 1,414 | 407.81 | 340.53 | 270.92 | 250.2 |
Long-Term Deferred Tax Liabilities | - | 374.86 | 424.73 | 574.84 | 611.99 | 381.48 |
Other Long-Term Liabilities | - | - | - | 59.16 | - | - |
Total Liabilities | - | 12,148 | 10,523 | 11,264 | 10,128 | 7,913 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | 11,061 | 11,033 | 10,899 | 10,899 | 10,899 |
Additional Paid-In Capital | - | 511.55 | 588.85 | 390.53 | 196.57 | 46.79 |
Retained Earnings | - | 26,871 | 25,650 | 26,245 | 23,192 | 19,188 |
Treasury Stock | - | -752.85 | -612.04 | -316.21 | -83.71 | -85.6 |
Comprehensive Income & Other | - | -4,513 | -4,394 | -4,015 | -4,006 | -4,062 |
Total Common Equity | 33,178 | 33,178 | 32,265 | 33,203 | 30,198 | 25,987 |
Minority Interest | - | 1,372 | 1,602 | 1,815 | 1,444 | 841.56 |
Shareholders' Equity | 34,550 | 34,550 | 33,866 | 35,018 | 31,642 | 26,828 |
Total Liabilities & Equity | - | 46,698 | 44,389 | 46,282 | 41,770 | 34,742 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 641.11 | 641.11 | 507.33 | 706.9 | 582.54 | 94.04 |
Net Cash (Debt) | 9,732 | 9,732 | 8,630 | 13,058 | 13,984 | 11,213 |
Net Cash Growth | 12.77% | 12.77% | -33.91% | -6.62% | 24.70% | 24.61% |
Net Cash Per Share | 0.85 | 0.85 | 0.74 | 1.10 | 1.17 | 0.94 |
Filing Date Shares Outstanding | 11,403 | 11,422 | 11,538 | 11,852 | 11,917 | 11,918 |
Total Common Shares Outstanding | 11,403 | 11,422 | 11,538 | 11,852 | 11,917 | 11,918 |
Working Capital | - | 12,073 | 12,254 | 16,562 | 14,999 | 13,110 |
Book Value Per Share | 2.90 | 2.90 | 2.80 | 2.80 | 2.53 | 2.18 |
Tangible Book Value | 30,285 | 30,285 | 29,512 | 30,822 | 28,090 | 25,411 |
Tangible Book Value Per Share | 2.65 | 2.65 | 2.56 | 2.60 | 2.36 | 2.13 |
Buildings | - | 5,955 | 5,565 | 5,389 | 4,639 | 4,135 |
Machinery | - | 10,549 | 9,943 | 9,194 | 7,317 | 6,723 |
Construction In Progress | - | 2,918 | 2,235 | 1,246 | 2,245 | 1,534 |